Sputtr.com | Alternative Search Engine

Antifungal

Introduction to Antifungal Drugs

653 Introduction to Antifungal Drugs WilliamE. Dismukes From the Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham School of Medicine In the UnitedStates, only 10 antifungal drugs are currently approved by the Food and Drug Administration (FDA) for the ...

ANTIFUNGAL PROPERTIES OF NEEM

ANTIFUNGAL PROPERTIES OF NEEM Overview Like neem's antibacterial and antiviral properties, its antifungal properties are often a given among scientists in India and other Asian nations where most of the current research is being conducted.

Overview of Antifungal Agents

Overview of Antifungal Agents George R.Thompson III, MD, FACP a, b , *,Jose Cadena, MD a, b, ThomasF. Patterson, MD a, b The number of agents available to treat fungal infections has increased by 30%since the year 2000, yet still only 15 agents are currently approved for clinical use.

C IGNA H EALTH C ARE C OVERAGE P OSITION - ), itraconazole ...

Page 1 of 4 Coverage Position Number: 8002 CIGNA HEALTHCARE COVERAGE POSITION Subject Oral Antifungal Therapies for Superficial Fungal Infections–

Antifungals

3 Antifungals 2007 V. Azole Antifungal Agents • MOA: Inhibits cytochrome P450 dependent 14-alpha lanosterol. Inhibition of this enzyme disrupts the synthesis of ergosterol, ...

ANTIFUNGAL DRUGS

Antifungal Agents • 1 ANTIFUNGAL DRUGS Fungal infections (mycoses) can be both superficial and systemic . Susceptibility: Broad-spectrum antimicrobial agents, AIDS, Immunosuppressant drugs, Cancer chemotherapy.

Antifungal Agents in Children WilliamJ. Steinbach, MD

Antifungal Agents in Children WilliamJ. Steinbach, MD a,b, * a Department of Pediatrics, Division of Pediatric Infectious Diseases, Box 3499, Duke University Medical Center, Durham, NC 27710, USA b Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC ...

Therapeutic Drug Monitoring of Antifungals: Pharmacokinetic ...

Cryptococcus neoformans. Clinical use of 5-FC is mainly limited to combination therapy with another antifungal, amphotericinB, for the treatment of cryptococcal meningitis as a result of the rapid selection of resistant isolates when used asmonotherapy.

Drug Monograph

PA Criteria Proposal 2002 Heritage Information Systems, Inc. All Rights Reserved. Drug Monograph Drug Monograph Drug/Drug Class: Voriconazole (Vfend ®) / Antifungal Prepared for: Missouri Medicaid Prepared by: Heritage Information Systems, Inc.

Antifungal Resistance in Pathogenic Fungi

ANTIMICROBIAL RESISTANCE• CID 2002:35 (1 November) •1073 ANTIMICROBIAL RESISTANCE INVITED ARTICLE GeorgeM. Eliopoulos, Section Editor Antifungal Resistance in Pathogenic Fungi Sofia Perea 1 and Thomas F. Patterson 1,2 1 Department of Medicine, Division of Infectious Diseases, The University ...